Operaciones Organovo Holdings, Inc. - ONVO CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.06 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024068% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.001846% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Estadísticas clave
| Cierre previo* | 2.22 |
| Abrir* | 2.24 |
| Cambio de 1 año* | -40.9% |
| Rango del día* | 2.12 - 2.29 |
| Rango de 52 semanas | 1.37-3.98 |
| Volumen medio (10 días) | 42.78K |
| Volumen medio (3 meses) | 2.51M |
| Capitalización de mercado | 17.69M |
| Ratio P/E | -100.00K |
| Acciones en circulación | 8.71M |
| Ingresos | 1.71M |
| EPS | -1.34 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 0.90 |
| Próxima fecha de resultados | N/A |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Mar 27, 2023 | 2.22 | 0.19 | 9.36% | 2.03 | 2.27 | 2.00 |
| Mar 24, 2023 | 1.98 | 0.07 | 3.66% | 1.91 | 1.98 | 1.91 |
| Mar 23, 2023 | 1.93 | -0.10 | -4.93% | 2.03 | 2.06 | 1.91 |
| Mar 22, 2023 | 1.99 | 0.06 | 3.11% | 1.93 | 2.03 | 1.91 |
| Mar 21, 2023 | 1.91 | 0.03 | 1.60% | 1.88 | 1.96 | 1.88 |
| Mar 20, 2023 | 1.88 | -0.08 | -4.08% | 1.96 | 1.97 | 1.84 |
| Mar 17, 2023 | 1.93 | 0.04 | 2.12% | 1.89 | 1.97 | 1.88 |
| Mar 16, 2023 | 1.94 | 0.05 | 2.65% | 1.89 | 1.98 | 1.88 |
| Mar 15, 2023 | 1.89 | 0.01 | 0.53% | 1.88 | 1.93 | 1.87 |
| Mar 14, 2023 | 1.94 | 0.05 | 2.65% | 1.89 | 1.99 | 1.85 |
| Mar 13, 2023 | 1.87 | 0.14 | 8.09% | 1.73 | 1.94 | 1.71 |
| Mar 10, 2023 | 1.78 | -0.08 | -4.30% | 1.86 | 1.86 | 1.74 |
| Mar 9, 2023 | 1.85 | -0.18 | -8.87% | 2.03 | 2.04 | 1.83 |
| Mar 8, 2023 | 2.05 | -0.07 | -3.30% | 2.12 | 2.12 | 2.02 |
| Mar 7, 2023 | 2.10 | -0.08 | -3.67% | 2.18 | 2.19 | 2.03 |
| Mar 6, 2023 | 2.21 | 0.03 | 1.38% | 2.18 | 2.23 | 2.17 |
| Mar 3, 2023 | 2.14 | -0.07 | -3.17% | 2.21 | 2.25 | 2.06 |
| Mar 2, 2023 | 2.19 | -0.02 | -0.90% | 2.21 | 2.21 | 2.08 |
| Mar 1, 2023 | 2.14 | -0.16 | -6.96% | 2.30 | 2.31 | 2.11 |
| Feb 28, 2023 | 2.34 | -0.08 | -3.31% | 2.42 | 2.42 | 2.28 |
Organovo Holdings, Inc. Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| No events scheduled | ||
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 1.5 | 0 | 2.196 | 3.091 | 4.603 |
| Ingresos | 1.5 | 0 | 2.196 | 3.091 | 4.603 |
| Coste de los ingresos, total | 0 | 0.328 | 0.482 | 1.03 | |
| Beneficio bruto | 0 | 1.868 | 2.609 | 3.573 | |
| Gastos totales de explotación | 12.979 | 16.826 | 23.671 | 30.365 | 39.874 |
| Gastos de venta/general/administración Gastos, total | 9.631 | 12.9 | 14.423 | 15.131 | 20.888 |
| Investigación y desarrollo | 3.206 | 1.077 | 5.051 | 14.752 | 17.956 |
| Ingresos de explotación | -11.479 | -16.826 | -21.475 | -27.274 | -35.271 |
| Ingresos por intereses (gastos), netos No operativos | 0.008 | 0.015 | 0.594 | 0.705 | 0.478 |
| Gain (Loss) on Sale of Assets | 0 | -0.019 | 0.113 | -0.063 | 0.004 |
| Ingresos netos antes de impuestos | -11.446 | -16.824 | -18.708 | -26.632 | -34.801 |
| Ingresos netos después de impuestos | -11.448 | -16.826 | -18.71 | -26.635 | -34.803 |
| Beneficio neto antes de partidas extra. Elementos | -11.448 | -16.826 | -18.71 | -26.635 | -34.803 |
| Ingresos netos | -11.448 | -16.826 | -18.71 | -26.635 | -34.803 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -11.448 | -16.826 | -18.71 | -26.635 | -34.803 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -11.448 | -16.826 | -18.71 | -26.635 | -34.803 |
| Beneficio neto diluido | -11.448 | -16.826 | -18.71 | -26.635 | -34.803 |
| Promedio ponderado de acciones diluidas | 8.7036 | 6.902 | 6.47781 | 5.769 | 5.3622 |
| BPA diluido sin partidas extraordinarias | -1.31532 | -2.43784 | -2.88832 | -4.61692 | -6.49043 |
| BPA normalizado diluido | -1.31532 | -2.17161 | -2.62603 | -4.60982 | -6.49092 |
| Otros, netos | 0.025 | 0.006 | 2.06 | 0 | -0.012 |
| Total de partidas extraordinarias | 0 | ||||
| Depreciation / Amortization | 0.142 | 0.041 | 1.142 | ||
| Gastos (ingresos) extraordinarios | 0 | 2.808 | 2.727 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Ingresos totales | 1.5 | 0 | 0 | 0 | 0 |
| Ingresos | 1.5 | 0 | |||
| Coste de los ingresos, total | 0 | ||||
| Beneficio bruto | 0 | ||||
| Gastos totales de explotación | 3.413 | 3.5 | 3.507 | 2.559 | 2.598 |
| Gastos de venta/general/administración Gastos, total | 2.265 | 2.569 | 2.823 | 1.975 | 1.921 |
| Investigación y desarrollo | 1.102 | 0.894 | 0.649 | 0.56 | 0.655 |
| Depreciation / Amortization | 0.046 | 0.037 | 0.035 | 0.024 | 0.022 |
| Gastos (ingresos) extraordinarios | 0 | 0 | |||
| Ingresos de explotación | -1.913 | -3.5 | -3.507 | -2.559 | -2.598 |
| Ingresos por intereses (gastos), netos No operativos | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
| Gain (Loss) on Sale of Assets | 0 | 0 | 0 | 0 | 0 |
| Otros, netos | 0 | 0 | 0 | 0.025 | 0 |
| Ingresos netos antes de impuestos | -1.911 | -3.498 | -3.505 | -2.532 | -2.596 |
| Ingresos netos después de impuestos | -1.911 | -3.5 | -3.505 | -2.532 | -2.596 |
| Beneficio neto antes de partidas extra. Elementos | -1.911 | -3.5 | -3.505 | -2.532 | -2.596 |
| Ingresos netos | -1.911 | -3.5 | -3.505 | -2.532 | -2.596 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -1.911 | -3.5 | -3.505 | -2.532 | -2.596 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -1.911 | -3.5 | -3.505 | -2.532 | -2.596 |
| Beneficio neto diluido | -1.911 | -3.5 | -3.505 | -2.532 | -2.596 |
| Promedio ponderado de acciones diluidas | 8.70551 | 8.7055 | 8.70533 | 8.69668 | 7.65275 |
| BPA diluido sin partidas extraordinarias | -0.21952 | -0.40204 | -0.40263 | -0.29115 | -0.33922 |
| BPA normalizado diluido | -0.21952 | -0.40204 | -0.40263 | -0.29115 | -0.33922 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 29.533 | 38.398 | 28.318 | 38.574 | 46.76 |
| Efectivo e inversiones a corto plazo | 28.675 | 37.364 | 27.356 | 36.477 | 43.726 |
| Efectivo y Equivalentes | 28.675 | 37.364 | 27.356 | 36.477 | 43.726 |
| Total deudores, neto | 0 | 0.111 | 0.558 | 1.028 | |
| Accounts Receivable - Trade, Net | 0 | 0.111 | 0.503 | 0.883 | |
| Total Inventory | 0 | 0.49 | 0.842 | ||
| Prepaid Expenses | 0.858 | 1.034 | 0.851 | 1.049 | 1.164 |
| Total Assets | 33.296 | 39.917 | 28.441 | 40.623 | 49.827 |
| Property/Plant/Equipment, Total - Net | 2.815 | 0.381 | 0 | 1.832 | 2.788 |
| Property/Plant/Equipment, Total - Gross | 3.886 | 1.383 | 0.415 | 6.413 | 6.856 |
| Accumulated Depreciation, Total | -1.071 | -1.002 | -0.415 | -4.581 | -4.068 |
| Intangibles, Net | 0.094 | 0.109 | 0.123 | 0.137 | 0.151 |
| Other Long Term Assets, Total | 0.854 | 1.029 | 0 | 0.08 | 0.128 |
| Total Current Liabilities | 1.383 | 0.721 | 1.81 | 3.737 | 4.658 |
| Accounts Payable | 0.415 | 0.281 | 0.72 | 0.628 | 0.464 |
| Accrued Expenses | 0.968 | 0.44 | 1.09 | 2.584 | 3.526 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0 | 0.525 | 0.668 | ||
| Total Liabilities | 3.087 | 0.721 | 1.81 | 4.325 | 5.241 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 1.704 | 0 | 0.588 | 0.583 | |
| Total Equity | 30.209 | 39.196 | 26.631 | 36.298 | 44.586 |
| Common Stock | 0.009 | 0.009 | 0.131 | 0.124 | 0.111 |
| Additional Paid-In Capital | 337.94 | 335.479 | 305.965 | 296.929 | 278.595 |
| Retained Earnings (Accumulated Deficit) | -307.739 | -296.291 | -279.465 | -260.755 | -234.12 |
| Other Equity, Total | 0 | ||||
| Total Liabilities & Shareholders’ Equity | 33.296 | 39.917 | 28.441 | 40.623 | 49.827 |
| Total Common Shares Outstanding | 8.71063 | 8.67049 | 6.52791 | 6.20077 | 5.55165 |
| Treasury Stock - Common | -0.001 | -0.001 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 29.533 | 31.171 | 34.303 | 36.658 | 38.398 |
| Efectivo e inversiones a corto plazo | 28.675 | 30.269 | 33.791 | 36.008 | 37.364 |
| Efectivo y Equivalentes | 28.675 | 30.269 | 33.791 | 36.008 | 37.364 |
| Total deudores, neto | 0 | ||||
| Accounts Receivable - Trade, Net | 0 | ||||
| Prepaid Expenses | 0.858 | 0.902 | 0.512 | 0.65 | 1.034 |
| Total Assets | 33.296 | 35.095 | 35.881 | 38.294 | 39.917 |
| Property/Plant/Equipment, Total - Net | 2.815 | 2.921 | 0.552 | 0.554 | 0.381 |
| Other Long Term Assets, Total | 0.948 | 1.003 | 1.026 | 1.082 | 1.138 |
| Total Current Liabilities | 1.383 | 2.006 | 1.675 | 0.964 | 0.721 |
| Accounts Payable | 0.415 | 0.605 | 0.958 | 0.577 | 0.281 |
| Accrued Expenses | 0.968 | 1.401 | 0.717 | 0.387 | 0.44 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.087 | 3.802 | 1.675 | 0.964 | 0.721 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 30.209 | 31.293 | 34.206 | 37.33 | 39.196 |
| Common Stock | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 |
| Additional Paid-In Capital | 337.94 | 337.113 | 336.526 | 336.145 | 335.479 |
| Retained Earnings (Accumulated Deficit) | -307.739 | -305.828 | -302.328 | -298.823 | -296.291 |
| Treasury Stock - Common | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 |
| Total Liabilities & Shareholders’ Equity | 33.296 | 35.095 | 35.881 | 38.294 | 39.917 |
| Total Common Shares Outstanding | 8.71063 | 8.70555 | 8.70545 | 8.69813 | 8.67049 |
| Other Liabilities, Total | 1.704 | 1.796 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -11.448 | -16.826 | -18.71 | -26.635 | -34.803 |
| Efectivo de actividades de explotación | -8.453 | -13.323 | -14.882 | -20.375 | -28.857 |
| Efectivo de actividades de explotación | 0.142 | 0.041 | 1.142 | 0.98 | 1.267 |
| Partidas no monetarias | 2.256 | 5.575 | 3.684 | 5.13 | 6.767 |
| Cash Taxes Paid | 0.002 | -0.002 | -0.002 | -0.003 | 0.002 |
| Cambios en el capital circulante | 0.597 | -2.113 | -0.998 | 0.15 | -2.088 |
| Efectivo de actividades de inversión | -0.409 | -0.393 | 0.747 | -0.076 | -0.292 |
| Gastos de capital | -0.409 | -0.405 | 0 | -0.079 | -0.296 |
| Otras partidas de flujo de caja de inversión, total | 0 | 0.012 | 0.747 | 0.003 | 0.004 |
| Efectivo procedente de actividades de financiación | 0.205 | 23.835 | 4.935 | 13.154 | 10.113 |
| Emisión (retiro) de acciones, neto | 0.251 | 23.839 | 4.996 | 13.377 | 10.113 |
| Emisión (amortización) de deuda, neta | 0 | ||||
| Efectos del cambio de divisas | 0 | 0.011 | |||
| Variación neta de la tesorería | -8.657 | 10.119 | -9.2 | -7.297 | -19.025 |
| Elementos de flujo de caja de financiación | -0.046 | -0.004 | -0.061 | -0.223 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -11.448 | -9.537 | -6.037 | -2.532 | -16.826 |
| Cash From Operating Activities | -8.453 | -6.912 | -3.556 | -1.413 | -13.323 |
| Cash From Operating Activities | 0.142 | 0.096 | 0.059 | 0.025 | 0.041 |
| Non-Cash Items | 2.256 | 1.429 | 0.841 | 0.415 | 5.575 |
| Cash Taxes Paid | 0.002 | 0.002 | 0 | 0 | -0.002 |
| Changes in Working Capital | 0.597 | 1.1 | 1.581 | 0.679 | -2.113 |
| Cash From Investing Activities | -0.409 | -0.356 | -0.223 | -0.194 | -0.393 |
| Capital Expenditures | -0.409 | -0.356 | -0.223 | -0.194 | -0.405 |
| Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | 0.012 |
| Cash From Financing Activities | 0.205 | 0.205 | 0.206 | 0.251 | 23.835 |
| Financing Cash Flow Items | -0.046 | -0.046 | -0.045 | 0 | -0.004 |
| Issuance (Retirement) of Stock, Net | 0.251 | 0.251 | 0.251 | 0.251 | 23.839 |
| Net Change in Cash | -8.657 | -7.063 | -3.573 | -1.356 | 10.119 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 5.2183 | 454752 | -6624 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.25 | 283225 | 151 | 2022-12-31 | LOW |
| ARK Investment Management LLC | Investment Advisor | 2.4591 | 214302 | -60565 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.691 | 147360 | -185 | 2022-12-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 1.2859 | 112057 | -7830 | 2022-12-31 | HIGH |
| Murphy (Keith E) | Individual Investor | 1.0721 | 93427 | 19607 | 2022-11-10 | |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7418 | 64641 | -151 | 2022-12-31 | LOW |
| Susquehanna International Group, LLP | Investment Advisor | 0.5815 | 50672 | 369 | 2022-12-31 | MED |
| Cohen (Douglas Jay) | Individual Investor | 0.3627 | 31607 | 19607 | 2022-11-10 | HIGH |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3194 | 27831 | 0 | 2022-12-31 | LOW |
| Morgan Stanley & Co. LLC | Research Firm | 0.3111 | 27113 | 10 | 2022-12-31 | MED |
| Stern (Adam K.) | Individual Investor | 0.225 | 19607 | 19607 | 2022-11-10 | HIGH |
| Joshi (Vaidehi) | Individual Investor | 0.225 | 19607 | 19607 | 2022-11-10 | |
| Milhous (Alison Tjosvold) | Individual Investor | 0.225 | 19607 | 19607 | 2022-11-10 | |
| Gobel (David) | Individual Investor | 0.225 | 19607 | 19607 | 2022-11-10 | HIGH |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1659 | 14461 | 0 | 2022-12-31 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.0753 | 6559 | -182 | 2022-12-31 | LOW |
| CGM-AZIMUT MONACO | Investment Advisor | 0.0631 | 5500 | 0 | 2023-01-31 | MED |
| UBS Financial Services, Inc. | Investment Advisor | 0.0482 | 4202 | -2041 | 2022-12-31 | LOW |
| Advisor Group, Inc | Investment Advisor | 0.0319 | 2783 | -224 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Organovo Holdings, Inc. Company profile
Sobre Organovo Holdings Inc
Organovo Holdings, Inc. es una empresa de biotecnología en fase inicial. La empresa se centra en la creación de tejidos tridimensionales (3D) de alta fidelidad que recapitulan aspectos clave de las enfermedades humanas. La empresa se centra en el intestino y está desarrollando tejidos 3D para la colitis ulcerosa (CU) y la enfermedad de Crohn (EC). La empresa utiliza su tecnología de plataforma para construir tejidos humanos funcionales en 3D que imitan aspectos clave de la composición, la arquitectura, la función y la enfermedad de los tejidos humanos nativos. Sus bioimpresoras NovoGen son dispositivos automatizados que permiten la fabricación de tejidos vivos en 3D compuestos por células de mamíferos. Los bioimpresores NovoGen pueden dispensar formulaciones de hidrogeles puros y también sirven como componentes importantes de la plataforma de fabricación y creación de prototipos de tejidos de la empresa. La empresa también pretende utilizar su plataforma de bioimpresión y las tecnologías 3D para tratar sus enfermedades objetivo.
| Industry: | Biotechnology & Medical Research (NEC) |
Suite 110
6275 Nancy Ridge Drive
92121
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com